Tick-Borne DNA Panel, B TICKPCR

Synonyms
Allscripts (AEHR) Order Name	Tick-Borne Panel PCR, B
Sunrise Clinical Manager (SCM) Order Name	Tick-Borne Panel PCR, B
Clinical Info	Evaluation of patients with suspected human monocytic ehrlichiosis, human granulocytic anaplasmosis, babesiosis, or Borrelia miyamotoi infection Evaluation of patients with a history of, or suspected, tick exposure who are presenting with fever, myalgia, headache, nausea, and other nonspecific symptoms Includes: Babesia species, PCR Ehrlichia/Anaplasma PCR, B Borrelia miyamotoi Detection PCR, B
Specimen Type	Blood
Container	Lavender Top Tube
Collection Instructions	Container/Tube: Lavender (EDTA) Top Tube Specimen: 1 mL whole Blood (0.3 mL min) Transport Temperature: Refrigerated Stability; 7 Days Refrigerated
Transport Instructions	Refrigerated
Specimen Stability	7 Days Refrigerated
Methodology	Real-Time Polymerase Chain Reaction (PCR)/DNA Probe Hybridization
Days Performed	TAT: 2-5 Days
Performing Laboratory	Mayo Medical Laboratories
CPT	87798 x 3
PDM	2059038
Result Interpretation Babesia species, Molecular Detection, PCR Negative Ehrlichia/Anaplasma, Molecular Detection, PCR Negative Borrelia miyamotoi, Molecular Detection, PCR Negative This panel does not detect Borrelia burgdorferi or Borrelia mayonii, the causative agents of Lyme disease in the United States. While Lyme polymerase chain reaction testing (PBORB / Lyme Disease [Borrelia burgdorferi], Molecular Detection, PCR, Blood) can be useful for detecting acute infection with B mayonii, this organism has a limited geographic distribution (upper Midwestern United States) and is therefore not included in this panel. Serology is the preferred method for detection of B burgdorferi.
Forms